C0015131||etomidate
C0033487||propofol
C1817756||immune function
C0152013||lung adenocarcinoma
C0015131||etomidate
C0033487||propofol
C1817756||immune function
C0152013||lung adenocarcinoma
C0920424||lung cancer surgery
C0002915||general anesthesia
C2603343||studied
C0015131||etomidate
C0473965||total intravenous anesthesia
C0033487||propofol
C0473965||total intravenous anesthesia
C1277791||percentage of CD4+
C1277791||percentage
C0543467||surgery
C4285770||percentage of CD8+ was higher
C1277791||CD4+ percentage
C4285769||CD8+ percentage was lower
C0015131||etomidate
C4049933||anesthesia
C1817756||immune function
C0152013||lung adenocarcinoma